International Clinical Trial: Specific clinical study on the safety of replacement fluids using hypertonic albumin solutions in plasma exchange therapy(Alb-PE-01)

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCTs071250083) titled 'Specific clinical study on the safety of replacement fluids using hypertonic albumin solutions in plasma exchange therapy(Alb-PE-01)' on Oct. 8.

Study Type: Interventional

Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose

Primary Sponsor: Adachi Masataka

Condition: Myasthenia gravis, Systemic lupus erythematosus, CIDP etc

Intervention: Medication (new replacement fluid)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 08/10/2025

Target Sample Size: 20

To know more, visit https://jrct.mhlw.go.jp/latest-detail...